Imaging agents for functional imaging of lymphatic structures
US7875260B2 · kind B2 · utility
0Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2007 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Aug 24, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M5/007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel imaging agents targeted to a lymph vascular cell receptor and a hyaluranon cell receptor are disclosed. The disclosed imaging agents incorporate biological molecules such as hyaluronic acid which bind to the receptors. Lymph vascular cell receptor expression may be related to the beginnings of tumor formation. As such, embodiments of the imaging agents may be used to stain lymph structures for detailed imaging of lymph architecture as well as serving as potential markers for tumor angiogenesis, tumor metastases, etc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.